Pharmascience Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMASCIENCE INC, and what generic and branded alternatives to PHARMASCIENCE INC drugs are available?
PHARMASCIENCE INC has four approved drugs.
There is one tentative approval on PHARMASCIENCE INC drugs.
Summary for Pharmascience Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 1 |
| Patent Litigation for Pharmascience Inc: | See patent lawsuits for Pharmascience Inc |
Drugs and US Patents for Pharmascience Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmascience Inc | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 207645-001 | Dec 8, 2017 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmascience Inc | DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 204607-001 | May 31, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmascience Inc | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 208392-001 | May 2, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmascience Inc | BUSULFAN | busulfan | INJECTABLE;INJECTION | 207050-001 | Mar 24, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
